India's Astrazeneca Pharma gains on quarterly profit jump

Astrazeneca Pharma India

12/02/2025 06:30

** Astrazeneca Pharma India  ASTR.NS  rises 2% to 7,609
rupees
    ** Q3 profit before exceptional item and tax jumps ~3.7x
y/y, helped by strong demand for its oncology products; rev up
44%
    ** Co incurred one-off 335.5 million rupees ($3.9 mln)
employee separation cost in the quarter
    ** More than 41,000 shares traded, 1.5x the 30-day avg
    ** Stock rose 32% in 2024

($1 = 86.8200 Indian rupees)

 (Reporting by Aleef Jahan in Bengaluru)
 ((aleefjahan.cs@thomsonreuters.com))